TOPU
RYTM icon

Trustees of Princeton University’s Rhythm Pharmaceuticals RYTM Stock Holding History

Trustees of Princeton University’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-47,643
Closed -$1.31M – 3
2019
Q1 		$1.31M Hold
47,643
– – 1.67% 3
2018
Q4 		$1.28M Hold
47,643
– – 1.95% 4
2018
Q3 		$1.39M Buy
+47,643
New +$1.51M 1.96% 3

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trustees of Princeton University's RYTM Position: Q2 2019 in Review

Trustees of Princeton University sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2019, closing a stake of 47,643 shares — an estimated $1.31M sold.

Trustees of Princeton University first reported a position in RYTM in Q3 2018 and held it in 3 quarters. The position peaked at $1.39M in Q3 2018. 84 funds tracked by Wall St. Rank hold RYTM as of Q2 2019.

  • Trustees of Princeton University reported no remaining Rhythm Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Trustees of Princeton University sold 47,643 Rhythm Pharmaceuticals shares in Q2 2019, an estimated $1.31M.
  • Trustees of Princeton University first reported a position in Rhythm Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Trustees of Princeton University's Rhythm Pharmaceuticals position peaked at $1.39M in Q3 2018.
  • 84 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2019.

Based on Trustees of Princeton University's 13F filing for Q2 2019, filed 8 Aug 2019.